Literature DB >> 11352182

Ontogeny of P-glycoprotein in mouse intestine, liver, and kidney.

B Mahmood1, M J Daood, C Hart, T W Hansen, J F Watchko.   

Abstract

BACKGROUND: P-glycoprotein (Pgp) is an ATP-dependent, integral plasma-membrane efflux pump that is constitutively expressed on (i) adult apical brush-border epithelial cells of the intestine, (ii) the bile canalicular face of hepatocytes, and (iii) the brush border epithelium of renal proximal tubules. This Pgp tissue distribution and localization affects the absorption, distribution, metabolism, and excretion of Pgp substrates. Little is known regarding the ontogeny of Pgp expression in these tissues.
METHODS: Postnatal expression of Pgp on brush border membranes of small intestine, liver, and kidney as a function of maturity from birth through adulthood was determined using Western immunoblotting and immunohistochemical techniques. Tissue was isolated from FVB mice at four different ages: day of life 0 (D0), day of life 7 (D7), day of life 21 (D21), and adult (Ad). The relative expression of Pgp protein on Western immunoblots was assessed by scanning densitometry and indexed as a percentage (mean+/-SEM) of the adult levels.
RESULTS: On Western immunoblots, Pgp expression was limited at birth (19+/-6% of Ad) and increased significantly with maturation in intestine (ANOVA, P<0.005). In contrast, hepatic (113+/-12% of Ad) and renal (96+/-15% of Ad) Pgp expression were at adult levels at birth. The tissue-specific developmental pattern of Pgp expression was confirmed by immunohistochemistry.
CONCLUSIONS: We conclude that Pgp is expressed in a tissue-specific and developmentally regulated fashion and speculate that developmental modulation of intestine-Pgp expression may affect the oral bioavailability of Pgp substrates.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11352182     DOI: 10.2310/6650.2001.33969

Source DB:  PubMed          Journal:  J Investig Med        ISSN: 1081-5589            Impact factor:   2.895


  11 in total

Review 1.  An update on expression and function of P-gp/ABCB1 and BCRP/ABCG2 in the placenta and fetus.

Authors:  Lyrialle W Han; Chunying Gao; Qingcheng Mao
Journal:  Expert Opin Drug Metab Toxicol       Date:  2018-08-03       Impact factor: 4.481

2.  Dual infection with Helicobacter bilis and Helicobacter hepaticus in p-glycoprotein-deficient mdr1a-/- mice results in colitis that progresses to dysplasia.

Authors:  Lillian Maggio-Price; Helle Bielefeldt-Ohmann; Piper Treuting; Brian M Iritani; Weiping Zeng; Andrea Nicks; Mark Tsang; Donna Shows; Phil Morrissey; Joanne L Viney
Journal:  Am J Pathol       Date:  2005-06       Impact factor: 4.307

Review 3.  Ontogeny of drug elimination by the human kidney.

Authors:  Nancy Chen; Katarina Aleksa; Cindy Woodland; Michael Rieder; Gideon Koren
Journal:  Pediatr Nephrol       Date:  2005-12-06       Impact factor: 3.714

4.  P-glycoprotein induction by breast milk attenuates intestinal inflammation in experimental necrotizing enterocolitis.

Authors:  Yigit S Guner; Ashanti L Franklin; Nikunj K Chokshi; Shannon L Castle; Elizabeth Pontarelli; Jin Wang; Larry Wang; Nemani V Prasadarao; Jeffrey S Upperman; Anatoly V Grishin; Henri R Ford
Journal:  Lab Invest       Date:  2011-07-25       Impact factor: 5.662

Review 5.  Pharmacokinetics of proton pump inhibitors in children.

Authors:  Catherine Litalien; Yves Théorêt; Christophe Faure
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

6.  Population pharmacokinetics and dose simulation of carvedilol in paediatric patients with congestive heart failure.

Authors:  Stefanie Albers; Bernd Meibohm; Thomas S Mir; Stephanie Läer
Journal:  Br J Clin Pharmacol       Date:  2007-11-08       Impact factor: 4.335

7.  Intestinal Permeability and Oral Absorption of Selected Drugs Are Reduced in a Mouse Model of Familial Alzheimer's Disease.

Authors:  Liang Jin; Yijun Pan; Natalie Lan Linh Tran; Leon N Polychronopoulos; Aparna Warrier; Kim L R Brouwer; Joseph A Nicolazzo
Journal:  Mol Pharm       Date:  2020-04-08       Impact factor: 4.939

Review 8.  Tacrolimus Pharmacokinetic and Pharmacogenomic Differences between Adults and Pediatric Solid Organ Transplant Recipients.

Authors:  Kwaku Marfo; Jerry Altshuler; Amy Lu
Journal:  Pharmaceutics       Date:  2010-09-09       Impact factor: 6.321

9.  The Toxic Effects of Polychemotherapy onto the Liver Are Accelerated by the Upregulated MDR of Lymphosarcoma.

Authors:  Alexandra V Sen'kova; Nadezhda L Mironova; Olga A Patutina; Tatyana A Ageeva; Marina A Zenkova
Journal:  ISRN Oncol       Date:  2012-11-29

10.  Development of a paediatric population-based model of the pharmacokinetics of rivaroxaban.

Authors:  Stefan Willmann; Corina Becker; Rolf Burghaus; Katrin Coboeken; Andrea Edginton; Jörg Lippert; Hans-Ulrich Siegmund; Kirstin Thelen; Wolfgang Mück
Journal:  Clin Pharmacokinet       Date:  2014-01       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.